The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Fridgescaping has completely taken over our TikTok feeds — and with it, our kitchens, too. While fridge organization ...

From national expectations to personal hurdles, athletes face intense stress that depletes vital nutrients, leading to ...

Maddy Gordon-Finlayson has found the cure to your Michaelmas madness with her expertly curated ‘dopamine menu’ ...

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.The ...

The US Food and Drug Administration (FDA ... treat psychosis acts on the same chemical that helps the brain communicate with ...

Arkansas Attorney General Tim Griffin filed a consumer protection lawsuit Monday against Google, YouTube and their parent ...

And to some people who take Ozempic or other GLP-1 medications, the lack of cravings feels like freedom. For others, life ...

A recent study sheds light on how consuming high-calorie, sugary, and fatty junk food can impact brain function and behaviour ... in processing pleasure and reinforcing behaviours through dopamine ...

Griffin stressed in announcing the lawsuit that the type of addiction created by Google, YouTube, corporate entity XXVI Holdings and parent company Alphabet is “something more sinister” than the ...

Substance use can lead to physical, psychological, social, economic, and legal harms. For example, alcohol use is associated ...

The US Food and Drug Administration (FDA) has approved xanomeline and trospium chloride capsules (Cobenfy) for the treatment of schizophrenia in adults. The drug is the first antipsychotic treatment ...